Skip to main content

Azithromycin Injection Shortage

Last Updated: June 1, 2021
Status: Resolved

Products Affected - Description
    • Azithromycin intravenous lyophilized powder for injection, Apotex, 500 mg, vial, 10 count, NDC 60505-6076-04 - discontinued
Reason for the Shortage
    • Apotex has discontinued azithromycin injection.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi had azithromycin injection on shortage due to increased demand.
    • Pfizer had azithromycin injection on shortage due to manufacturing delays.
    • Slate Run Pharmaceuticals had seen increased demand.
    • Sun Pharma is not currently manufacturing azithromycin injection.
Available Products
    • Zithromax intravenous lyophilized powder for injection, Pfizer, 500 mg, vial, 10 count, NDC 00069-3150-83
    • Azithromycin intravenous lyophilized powder for injection, Athenex, 500 mg, vial, 10 count, NDC 70860-0100-10
    • Azithromycin intravenous lyophilized powder for injection, AuroMedics, 500 mg, vial, 10 count, NDC 55150-0174-10
    • Azithromycin intravenous lyophilized powder for injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 63323-0398-10
    • Azithromycin intravenous lyophilized powder for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-0144-11
    • Azithromycin intravenous lyophilized powder for injection, Slate Run Pharmaceuticals, 500 mg, vial, 10 count, NDC 70436-0019-82

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated June 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 14, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer